ALEXANDRA FISHER: Open Payments
NPI 1285306910 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,217 in 36 payments from 18 companies in 2025. Trend: 2023 $1,046 · 2024 $1,687 · 2025 $2,217
Food & beverage: $2,217
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $491 |
| Novo Nordisk Inc | 5 | $379 |
| Amgen Inc. | 2 | $205 |
| Xeris Pharmaceuticals, Inc. | 2 | $169 |
| Exact Sciences Corporation | 2 | $120 |
| Dexcom, Inc. | 1 | $115 |
| Daiichi Sankyo Inc. | 1 | $108 |
| Teva Pharmaceuticals USA, Inc. | 1 | $103 |
| Madrigal Pharmaceuticals | 1 | $97 |
| Phathom Pharmaceuticals, Inc. | 1 | $97 |
Products named: BREZTRI, Wegovy, Ozempic, AIRSUPRA, DEXCOM G7 GSS (161), INJECTAFER, REPATHA, AUSTEDO XR.
Industry payments across MD — which companies pay providers there.
